Being affected by several cardiometabolic diseases such as diabetes, heart disease and stroke, is linked to a greatly increased risk of dementia and Alzheimer’s disease.
Teenagers who reported feeling optimism, happiness, self-esteem, belongingness, and feeling loved and wanted were more likely to reach their 20s and 30s in good cardiometabolic health compared to teens with fewer of these positive mental health assets, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
A change to Medicare policy surrounding heart transplant may lead to increased inequities in access to transplant for patients with heart failure, a new study finds. Results reveal that patients receiving Left Ventricular Assist Devices at transplant-capable centers had 79% higher odds to receive a bridge-to-transplant designation than patients treated at LVAD-only centers.
Reformulating packaged foods available in Australia to contain less sodium may save about 1,700 lives per year, according to a new study.
Sessenta anos atrás, havia poucas opções de tratamento para crianças que nasciam com alguma cardiopatia estrutural. Inovações em terapias têm transformado a cardiopatia congênita em uma condição que geralmente pode ser administrada na vida adulta. Neste alerta dos especialistas, cardiologistas da Mayo Clinic explicam como a doença pode mudar ao longo da vida.
مدينة روتشستر، ولاية مينيسوتا - قبل ستين عامًا، كانت خيارات العلاج قليلة بالنسبة للأطفال المولودين بعيوب في بنية القلب. منذ ذلك الحين، حوَّلت الابتكارات في العلاجات أمراض القلب الخلقية إلى حالة يمكن إدارتها طوال فترة البلوغ في معظم الأحيان. في تنبيه الخبراء هذا، يوضح أطباء القلب في مايو كلينك كيف يمكن للمرض أن يتغير على مدار الحياة.
罗切斯特，明尼苏达州— 在60年前，生来患有结构性心脏缺陷的孩子可选择的治疗方案很少。从那以后，疗法不断创新，使先天性心脏病成为一种通常可在整个成人期得到管理的疾病。在本次专家提醒中，妙佑医疗国际的心脏病专家说明了该疾病在患者的一生中可能发生的变化。
Hace sesenta años, las opciones de tratamiento para un niño que nacía con una cardiopatía estructural eran pocas. Desde entonces, las innovaciones en las terapias han transformado la enfermedad cardíaca congénita en una afección que se puede tratar durante la adultez. En este alerta para los expertos, los cardiólogos de Mayo Clinic explican cómo puede cambiar la enfermedad durante la vida.
A novel rooming-in program at Children’s Healthcare of Atlanta provided greater peace of mind for families of infants with critical congenital heart disease (CCHD) and the pediatric nurses preparing the infants for discharge.
A newly published study from York University sheds light on the biological underpinnings in sex differences in obesity-related disease, with researchers observing “striking” differences in the cells that build blood vessels in the fatty tissue of male versus female mice.
On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist, tending to patients in his cardio-oncology clinic. His schedule is packed to the brim with cancer patients. But not patients with heart cancer. The largest number of patients he sees are cancer patients who have developed, or are at risk of developing, heart damage in response to their chemotherapy regimens.
The medical emergency suffered by Damar Hamlin of the Buffalo Bills underscores the importance of speed when responding to cardiac arrest. Two Penn State Health physicians offer guidance.
Risk of severe COVID-19 continues to outweigh rare risk of post-vaccination myocarditis
Buffalo Bills safety Damar Hamlin, 24, remains hospitalized in "critical condition" after experiencing cardiac arrest when he collapsed mid-game against the Cincinnati Bengals on Monday night.
Loyola Medicine sports medicine and cardiology experts are available today to discuss the incident involving Buffalo Bills safety Damar Hamlin, who suffered a cardiac arrest on the field following a tackle during Monday night’s football game against the Cincinnati Bengals.
With the successful completion of back-to-back Christmas heart transplants, the University of Chicago Medicine set a new heart transplantation record for the state of Illinois, surpassing its own previous high-water mark for heart transplants. The Hyde Park-based academic health system has performed 66 heart transplants so far in 2022, surpassing last year's record of 61.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a recognition awarded to select U.S. medical centers that have a record of superior clinical outcomes resulting from evidence-based, guideline-directed degenerative mitral valve repair.
Health article about how the holidays can add stress to your life, and left unchecked, the stress and anxiety can be detrimental to physical and mental health, including heart health.
Researchers identified a protein linked with the onset of anthracycline-associated cardiac toxicity. In two studies conducted in women undergoing treatment for breast cancer, levels of a protein known as hemopexin circulating in the blood were associated with increased cardiac toxicity.
The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of Cardiology: interventional cardiologist Aakriti Gupta, MD, electrophysiologists Eric Braunstein, MD, and Archana Ramireddy, MD, and adult congenital cardiologist Prashanth Venkatesh, MD.
In a new study evaluating the Mediterranean diet and adverse pregnancy outcomes, investigators from the Smidt Heart Institute at Cedars-Sinai found that women who conceived while adhering to the anti-inflammatory diet had a significantly lower risk of developing preeclampsia during pregnancy.
The evidence-based health benefits of walking continue to accumulate, according to ongoing research by a University of Massachusetts Amherst physical activity epidemiologist, who leads an international consortium known as the Steps for Health Collaborative.
The University of Chicago Medicine transplant team performed the health system's first donated-after-circulatory death (DCD) heart transplant on Nov. 19, 2022. The DCD technique is expected to help heart patients get transplants faster. Donor hearts are traditionally recovered from brain-dead donors, a process known as donation after brain death (DBD).
Using the CRISPR-Cas9 gene editing system, UT Southwestern researchers corrected mutations responsible for a common inherited heart condition called dilated cardiomyopathy (DCM) in human cells and a mouse model of the disease.
Drinking two or more cups of coffee a day was associated with twice the risk of death from cardiovascular disease among people with severe hypertension compared to non-coffee drinkers, in a study of more than 18,600 men and women in Japan.
Nothing beats a good soak in a hot bath, and when it really hits the spot, you can almost feel your worries and ailments diffusing out into steam.
Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.
Older heart failure patients who feel that they have lost their social role amongst friends and family are more likely to suffer poor clinical outcomes.
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells—cells that control your heartbeat—can “fight back” against therapies to biologically correct abnormal heartbeat rates.
Researchers funded by the British Heart Foundation (BHF) at the University of Bristol have developed ‘stem cell plasters’ to revolutionise the way surgeons treat children living with congenital heart disease, so they don’t need as many open-heart operations.
Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway. The study, published December 19 in the Journal of Experimental Medicine (JEM), suggests that inhibiting this pathway could reduce the chances of cancer survivors suffering heart disease later in life.
The world-renown journal Nature, named Muhammad Mohiuddin, MD, DSc, Program and Scientific Director of the Cardiac Xenotransplantation Program at the University of Maryland School of Medicine (UMSOM), on its annual list of 10 people who helped shaped science in 2022.
New research at Cleveland Clinic expands the link between what we eat and how the gut microbiome impacts our susceptibility to develop different diseases – in this case, how a specific gut microbe-generated byproduct is linked to heart failure risk.
With modern therapies for heart failure (HF) with reduced ejection fraction (HFrEF), some patients can improve their cardiac function during treatment.
Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when she was surprised to hear that a cardiologist was asked to come into the exam room.
Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease. Investigators will take a novel approach to assess risk: by simultaneously evaluating heart function and the relationship between the heart and the aorta, the large artery that conveys oxygen-rich blood from the heart’s left ventricle to the rest of the body.
Dr. Ryan Kaple joins structural heart colleagues Dr. Tilak Pasala and Dr. Lucy Safi to offer advanced clinical trials and surgical systems that enhance patient outcomes
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone. The surgery also marked UCSF Health’s first donation after circulatory death (DCD) heart transplant, a procedure performed by only about twenty health systems in the U.S.
Researchers have uncovered a protein produced by the immune system, suPAR, that causes atherosclerosis. Investigators say it's the first immune target to treat cardiovascular disease, which affects over 1 billion people worldwide. Researchers believe treatment could be developed within five years.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
